'Triple therapy' presentation slideshows

Advances in the Treatment of Chronic Hepatitis C

Advances in the Treatment of Chronic Hepatitis C. Gregory T Everson, MD Professor of Medicine Director of Hepatology University of Colorado Denver. Disclosures.

980 views • 86 slides

Advances in the Treatment of Chronic Hepatitis C

Advances in the Treatment of Chronic Hepatitis C. Gregory T Everson, MD Professor of Medicine Director of Hepatology University of Colorado Denver. Disclosures.

1.02k views • 86 slides

Dual Anti Platelet Therapy and COUMADIN After PCI

836 views • 69 slides

PRINCIPLES OF DRUG THERAPY IN GASTROINTESTINAL DISEASES

827 views • 61 slides

Management of PUD in 2018: Bugs & Drugs

432 views • 42 slides

What are Antiretrovirals?

537 views • 34 slides

Advantages of New Generation Direct Acting Antivirals (DAAs) Tarik Asselah MD, PhD

438 views • 29 slides

Hepatitis C Nonresponders

332 views • 24 slides

WOEST

The WOEST Trial: First randomised trial comparing two regimens with and without aspirin in patients on oral anticoagulant therapy undergoing coronary stenting. WOEST. ESC, Hotline III, Munchen, August 28th, 2012.

426 views • 23 slides

HIV in Pregnancy

HIV in Pregnancy. Max Brinsmead PhD FRANZCOG May 2011. Human Immunodeficiency Virus. HIV is a Lentivirus A member of the Retrovirus family Infects helper T cells (CD4), macrophages & mucosal dendritic cells Depletes CD4 numbers & thereby cell-mediated immunity

1.55k views • 19 slides

194 views • 19 slides

About Resistance

173 views • 17 slides

American Journal of Cardiology 2008; 102: 1618-1623

Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy

267 views • 14 slides

Diabetes Mellitus 101 for Cardiologists (and Alike): 2015

Diabetes Mellitus 101 for Cardiologists (and Alike): 2015. An Aggressive Pathophysiologic Approach to Therapy of Type 2 Diabetes in Cardiometabolic Patients: Looking at Diabetes Medications with a Cardiologists Eye. Part 16. Stan Schwartz MD,FACP Affiliate, Main Line Health System

135 views • 13 slides

Antiretroviral therapy

Antiretroviral therapy. ARVs cannot cure the HIV virus ARVs prevent the virus from multiplying: - reduce the levels of virus in the blood - immune system has opportunity to recover People on ARVs can remain well for many years . Antiretroviral therapy.

1.03k views • 11 slides

ELISA II Trial

ELISA II Trial. ELISA II Trial. Presented at The European Society of Cardiology Hot Line Session 2005 Presented by Dr. Saman Rasoul. ELISA II Trial.

228 views • 8 slides

ELISA II Trial

ELISA II Trial. ELISA II Trial. Presented at The European Society of Cardiology Hot Line Session 2005 Presented by Dr. Saman Rasoul. ELISA II Trial.

209 views • 8 slides

IL28B in the Era of DAA Therapy: Ten Years Too Late?

85 views • 8 slides

CASE 2

CASE 2 . 52 yo man HIV positive 5 yrs ago CAD with previous MI 3 yrs ago/Hypertensive/Hypothyroidism Tenofovir /FTC/ Raltegravir x 4 yrs CD4 700 HIV Viral Load<40. CASE 2 .

192 views • 7 slides

Switch to LPV/r monotherapy

Switch to LPV/r monotherapy. Pilot LPV/r M03-613 LPV/r Mono KalMo OK OK04 KALESOLO MOST HIV-NAT 077. OK Study: Switch LPV/r + 2NRTIs to LPV/r monotherapy. Design. Randomisation 1 : 1 Open-label. W48. N = 21. 42 HIV+ ? 18 years On 2 NRTIs + LPV/r > 4 weeks

53 views • 5 slides